Advertisement

Advertisement

39th Annual Miami Breast Cancer Conference

Breast Cancer

Strides Are Being Made in the Treatment of Brain Metastases From Breast Cancer

New drugs for HER2-positive breast cancer are able to overcome some of the obstacles that have made brain metastases challenging to treat, according to Mark Pegram, MD, the Susy Yuan-Huey Hung Profess...

Breast Cancer
Immunotherapy

Demystifying Immunotherapy for Early-Stage Triple-Negative Breast Cancer

Immunotherapy has become a potential strategy in treating triple-negative breast cancer, though many questions remain to be answered before long-term survival is achieved by all patients. This exciti...

Breast Cancer
Supportive Care

Advances in Managing Cardiac Side Effects Associated With Breast Cancer Treatment

Guideline-directed medical therapy for the prevention and treatment of cardiotoxicity is improving quality of life and oncologic outcomes associated with breast cancer treatment, according to Jean-Ber...

Breast Cancer

Emerging Endocrine Therapies for the Management of Breast Cancer

Novel hormonal therapies for breast cancer could provide additional therapeutic options for patients with hormone receptor–positive breast cancer. The emerging landscape for these new agents was descr...

Breast Cancer

PARP Inhibitors in the Treatment of Breast Cancer: What’s Next?

In patients with breast cancer tumors harboring BRCA1 and BRCA2 mutations, inhibitors of poly (ADP-ribose) polymerase (PARP) have emerged as essential therapeutic agents. What more needs to be done to...

Advertisement

Advertisement



Advertisement